ASP Isotopes

ASP Isotopes Cash Conversion

The Cash Conversion Rate (OCF/Net Income) of ASP Isotopes (ASPI) as of Nov 18, 2026 is 21.58 %. In the previous year, Cash Conversion Rate (OCF/Net Income) was 51.63 % — a change of -58.21% (lower).

Cash Conversion

21.58 %

YoY

-58.21%

Last updated:

Cash Conversion Rate (OCF/Net Income) of ASP Isotopes is 2025 21.58 % . Cash Conversion Rate (OCF/Net Income) of ASP Isotopes was 2024 51.63 % . It decreases by -58.21% lower compared to the previous year.

The ASP Isotopes Cash Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion
Date
Cash Conversion
Jan 1, 2021
22.15 USD
Jan 1, 2022
59.45 USD
Jan 1, 2023
33.23 USD
Jan 1, 2024
51.63 USD
Jan 1, 2025
21.58 USD
The ASP Isotopes Cash Conversion history
YEARCash ConversionYoY
21.58 %-58.21%
51.63 %+55.37%
33.23 %-44.10%
59.45 %+168.38%
22.15 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ASP Isotopes Stock analysis

What does ASP Isotopes do? ASP Isotopes, Inc. generates revenue through the development and commercialization of enriched isotopes using its Aerodynamic Separation Process (ASP technology). The company focuses on producing Carbon-14 (C-14), Molybdenum-100 (Mo-100), and Silicon-28 (Si-28) for specialized markets, with plans to expand into Uranium-235 (U-235) for the nuclear energy sector. Its subsidiaries, ASP Isotopes Guernsey Limited and Enriched Energy LLC, handle high-value isotope production and uranium development, respectively. The company licenses ASP technology from Klydon Proprietary Ltd for all isotope-related activities. The target customers for C-14, Mo-100, and Si-28 are highly specialized end markets requiring low-volume, high-value isotopes. Enriched Energy LLC specifically targets the nuclear energy market with uranium products. ASP Isotopes Guernsey Limited focuses on niche applications where isotope enrichment is critical, such as medical and industrial uses. The company’s revenue model relies on the sale of these enriched isotope products to specialized industries rather than mass-market consumers. ASP Isotopes, Inc. operates under a pre-commercial stage, meaning it is still developing its production capabilities and has not yet achieved full-scale commercialization. The company’s initial revenue streams will come from the sale of C-14, Mo-100, and Si-28, with future expansion into U-235 expected to diversify its product portfolio. The Aerodynamic Separation Process (ASP technology) is central to its business model, enabling the enrichment of natural isotopes into higher concentration products for specialized applications. ASP Isotopes is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ASP Isotopes stock

Cash Conversion Rate (OCF/Net Income) of ASP Isotopes is 21.58 % in 2025.

Cash Conversion Rate (OCF/Net Income) of ASP Isotopes changed from 51.63 % to 21.58 %, representing a -58.21% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Rate (OCF/Net Income) ASP Isotopes since 2006 – with annual values, charts, and detailed analysis.

Cash conversion measures how effectively net income converts to operating cash flow. Ratios above 100% indicate high-quality, cash-backed earnings.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Rate (OCF/Net Income)'s ASP Isotopes with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Rate (OCF/Net Income)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Rate (OCF/Net Income).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — ASP Isotopes

All Key Metrics — ASP Isotopes